as the potential for the first human trials of somatic cell gene therapy nears , two ethical issues are examined : problems of moral choice for members of institutional review boards who consider the first protocols , for parents , and for the clinical researchers , and the special protections that may be required for the infants and children to be involved , and ethical objections to somatic cell therapy made by those concerned about a putative inevitable progression of genetic knowledge from therapy to mass genetic engineering in human reproduction .
C0021270
infants
C0008059
children